NaCl transport across the opercular epithelium of Fundulus heteroclitus is inhibited by an endothelin to NO, superoxide, and prostanoid signaling axis. Am J Physiol Regul Integr Comp Physiol 286: R560-R568, 2004. First published November 20, 2003 10.1152/ajpregu.00281.2003.-Recent evidence suggests that paracrine signaling agents, such as endothelin (ET), nitric oxide (NO), superoxide (O 2 Ϫ ), and prostanoids can modulate mammalian renal function by affecting both hemodynamic and epithelial ionic transport pathways. Since these signaling pathways have been described in fish blood vessels, we hypothesized that they may control salt transport across the gill epithelium-the primary site of ion excretion in marine teleost fishes. We found that ET, the NO donors sodium nitroprusside and spermine NONOate, and the prostanoid PGE2 each can produce a concentration-dependent reduction in the short circuit current (I sc) across the isolated opercular epithelium of the killifish (Fundulus heteroclitus), the generally accepted model for the marine teleost gill epithelium. Sarafotoxin S6c was equipotent to ET-1, suggesting that ET B receptors are involved. Incubation with N G -nitro-L-arginine methyl ester (L-NAME) or indomethacin reduced the effect of subsequent addition of SRXS6c by 17 and 89%, respectively, suggesting the presence of an ET to NO and PGE axis. The effects of L-NAME and indomethacin were not additive, but the superoxide dismutase mimetic 4-hydroxy-2,2,6,6-tetramethylpiperidine 1-oxyl (TEMPOL) reduced the effect of SRXS6c by 34% and preincubation with L-NAME, indomethacin, and TEMPOL reduced the SRXS6c response to zero. This suggests a direct role for O 2 Ϫ in this axis. COX-2 appears to be the major enzyme involved in this axis because the specific COX-2 inhibitor NS-398 was twice as effective as the COX-1 inhibitor SC560 in inhibiting the SRXS6c effect. The I sc was stimulated by the EP 2 agonist butaprost and inhibited by the EP1,3 agonist sulprostone, suggesting both stimulatory and inhibitory PGE receptors in this tissue. Carbaprostacyclin (PGI 2 analog), thromboxane A2, PGF 2␣, and PGD2 did not affect the Isc. Our data are the first to suggest the importance of an ET-stimulated and NO-, O 2 Ϫ -, and PGE 2-mediated signaling axis that can modify active extrusion of NaCl across the killifish opercular epithelium and, by inference, the marine teleost gill epithelium. fish; gill transport; paracrine signaling SINCE THE DISCOVERY of the first endothelin (ET) in 1988 (61), it has become clear that this family of paracrine signaling peptides (ET-1, ET-2, ET-3) plays a significant role in mammalian physiology and pathophysiology (e.g., 28). The cardiovascular effects of ETs are mediated by two receptors, termed ET A and ET B (e.g., 31), which are expressed in both vascular smooth muscle and endothelial cells. The two receptors can be discriminated by radioligand displacement and/or relative agonist sensitivity, because the agonist sarafotoxin S6c (SRXS6c) shows very high specificity for ET B receptors (e.g., 36). ET produces potent constriction in a variety of vessels via activation of either ET A or ET B receptors (e.g., 54). ET binding to the endothelial ET B receptors stimulates the release of the endothelium-derived relaxing factors (EDRF) nitric oxide (NO) and prostacyclin (PGI 2 ) (8). Indeed, infusion of ET into mammals produces a biphasic response: transient hypotension followed by a more significant and prolonged hypertension (e.g., 7), and the initial hypotension can be blocked by inhibition of NO synthase (NOS) (9), suggesting that NO is the primary EDRF.
shows very high specificity for ET B receptors (e.g., 36 ). ET produces potent constriction in a variety of vessels via activation of either ET A or ET B receptors (e.g., 54) . ET binding to the endothelial ET B receptors stimulates the release of the endothelium-derived relaxing factors (EDRF) nitric oxide (NO) and prostacyclin (PGI 2 ) (8) . Indeed, infusion of ET into mammals produces a biphasic response: transient hypotension followed by a more significant and prolonged hypertension (e.g., 7) , and the initial hypotension can be blocked by inhibition of NO synthase (NOS) (9) , suggesting that NO is the primary EDRF.
ET-like immunoreactivity also has been found in gill, heart, or neural tissue in all major groups of fishes, including agnathans, elasmobranchs, and teleosts (e.g., 27, 57) , and a trout ET recently has been purified, sequenced, and synthesized (60) . Infusion of either this peptide or human ET-1 produces a complex suite of cardiovascular responses in the trout, including a triphasic pressure change (pressor-depressor-pressor) in the dorsal aorta produced by changes in cardiac output, gill resistance, systemic resistance, and venous compliance (22) . In vitro, ET-1 produces substantial constriction in blood vessels isolated from a variety of fish species (e.g., 16, 18, 55, 60) . Pharmacological and physiological protocols have delineated both ET A and ET B receptors in fish blood vessels and gill tissue (e.g., 15, 16, 18) .
NOS has been identified in central and peripheral neural tissue in a variety of fish species (e.g., 6, 20, [48] [49] [50] and also in neurons and epithelial cells in the gill of a catfish (e.g., 63 ) and the killifish (12) . Prostanoids are produced in various tissues (including the gill, see below) in a variety of fish groups (e.g., 5, 29) . NO (or an NO donor) is dilatory in teleost vessels (e.g., 39, 53) but constrictory in elasmobranch and hagfish vessels (e.g., 17, 18) and produces a biphasic response (constriction followed by dilation) in the lamprey ventral aorta (18) . Prostanoids, however, are dilatory in vessels isolated from a variety of fish species (e.g., 14, [17] [18] [19] , although it is unclear if the effector is PGI 2 or PGE 2 , because of potential crossreactivity with receptors. Despite these uncertainties, it is clear that modern representatives of the most ancient vertebrate lineages express the components of the paracrine signaling system that involves ET, NO, and prostanoids.
Both ET A and ET B receptors also have been identified in the mammalian kidney (e.g., 4) and ET produces natriuresis and diuresis at concentrations too low to affect systemic or renal hemodynamics (e.g., 47 ). These data suggest that ET can affect tubular transport as well as perfusion, and various studies have shown that ET inhibits salt and water reabsorption in the cortical and medullary thick ascending limbs (THAL) (e.g., 45 ), as well as the cortical and medullary collecting ducts (56) . Like ET, NO can produce natriuresis and diuresis without concomitant changes in either glomerular filtration or renal blood flow, and the tubular effects appear to be primarily in the proximal tubule, THAL, and collecting duct (reviewed in 43) . Moreover, NOS is expressed in renal tissue (e.g., 23, 35) . Recent evidence suggests that superoxide (O 2 Ϫ ) also may have measurable effects on THAL transport, either directly or via interactions with NO (e.g., 44). Prostanoids (generated by cyclooxygenase; COX) also can have epithelial as well as vascular effects in the kidney, inhibiting salt uptake in the THAL and collecting duct. The major effector appears to be PGE 2 , acting via EP 1 and/or EP 2 receptors, although receptors for other prostanoids (e.g., thromboxane A 2, PGI 2 , PGF 2␣ , and perhaps, PGD 2 ) are also expressed in renal tissue (reviewed in 3). In addition, both COX-1 and COX-2 are expressed in renal tubules (e.g., 59 ). We are unaware of any published studies suggesting that the renal effects of ET can be linked to prostanoid production.
The gill is the primary site of osmoregulation in fishes, and the gill epithelium expresses many of the transport proteins found in the mammalian nephron. These transporters mediate NaCl excretion or uptake, depending on osmoregulatory needs of the fish (e.g., 32). For example, marine teleosts are hypoosmotic to their environment and use the gill epithelium to excrete the excess NaCl that diffuses inward across the gill, as well as that absorbed to drive intestinal uptake of water after ingestion of seawater to offset the osmotic loss of water across the gill epithelium (e.g., 24). There is good evidence that this NaCl transport system can be modulated by circulating hormones, such as cortisol, prolactin, growth hormone, and IGF, thyroid hormones, and arginine vasotocin (fish equivalent of vasopressin) and adrenergic neurotransmitters (e.g., 12). The role(s) of paracrine agents such as ET, NO, O 2 Ϫ , and prostanoids on teleost fish gill transport remain largely unexamined, however. The extant literature consists of two early studies (11, 58) that showed that prostanoids inhibit the short circuit current (I sc ) across the opercular epithelium of the killifish (Fundulus heteroclitus). This tissue is the standard model of the branchial epithelium of marine teleost fishes because both tissues express the same cell types (e.g., mitochondrion-rich cells, pavement cells, and mucous cells), and the opercular epithelium can generate an I sc that is the result of net transport of Cl Ϫ across the epithelium (from basolateral to apical), with Na ϩ following passively via paracellular channels (26) .
In the present study we examined the effects of ET, NO, and prostanoids on the I sc across the killifish opercular epithelium. Our data provide the first evidence for an ET to NO-O 2 Ϫ -PGE 2 axis of inhibition involving ET B receptors, NOS and COX-2. PGE 2 appears to be the major effector in this axis, not NO, and the effect is mediated via EP 1 and/or EP 3 receptors. In addition, there is some evidence for a stimulatory, EP 2 -mediated receptor system. We found no evidence that other prostanoids (e.g., PGI 2 , thromboxane A 2, PGF 2␣ , or PGD 2 ) are involved.
MATERIALS AND METHODS
Adult killifish (Fundulus heteroclitus, ϳ5 g; both sexes) were collected by minnow trap in North East Creek, Mt. Desert Island, ME, during the summers of 1999-2002 and maintained in running seawater aquariums (16-20°C) for at least 24 h before death by cervical section and pithing. Gill operculae were removed, and the inner epithelium was removed by dissection under a microscope. The tissue was mounted over a 3 mm diameter aperture recessed in a Lucite plate and held in place by a small amount of silicone grease and a Lucite ring to minimize edge damage. The plate was inserted into a Lucite Ussing Chamber (Jim's Instruments) so that the 3 mm epithelial circle separated two chambers, each containing 2 ml of killifish Ringer (26) bubbled with 100% oxygen. Each chamber had ports to allow for aeration, solution addition, and removal and the insertion of AgAgCl 2 electrodes to measure transepithelial electrical potential and produce an I sc. The output from these electrodes was monitored by a University of Iowa model 742C dual voltage clamp and recorded and saved by a Biopac MP100 data-acquisition system, using AcqKnowledge software on a Macintosh computer. Experiments were initiated only if and when a stable I sc (Isc Ͼ 50 A/cm 2 ) and resistance (Ͼ35 ohms/cm 2 ) were reached, usually within 30 min. During the course of each experiment, electrical resistance was monitored by the automatic generation of a Ϯ1 mV pulse every minute by the voltage clamp and recording the I sc deflection. No systematic changes in tissue resistance were observed in the course of any of the experiments. In all experiments, equal volumes of solution (agonist/inhibitor vs. carrier) were added to both sides of the tissues (experimental and control) to avoid volume and osmotic effects, because our initial studies confirmed that even a 2% osmolarity differential across this epithelium can affect the I sc (33) .
Experimental chemicals were solubilized according to manufacturer's instructions, and the final concentrations used were determined from our earlier studies with these agonists/inhibitors or from published studies from other laboratories. In each case, the substance was dissolved in the appropriate solvent, subdivided, stored either frozen (Ϫ70 or Ϫ20°C) or at 4°C, and made up to the desired concentration by further dilution in the solvent and/or in the experimental medium (killifish Ringer) the day of the experiment. The final volume of agonist/inhibitor added ranged from 0.1 to 4% of the initial volume of the experimental medium. ET-1 (human) and SRXS6c (American Peptide, Sunnyvale, CA) were dissolved in 1% acetic acid and 50% DMSO, respectively, lyophilized (ET-1 only), and stored at Ϫ20°C. Sodium nitroprusside (Sigma, St. Louis, MO), TEMPOL (4-hydroxy-2, 2, 6, 6-tetramethylpiperidine 1-oxyl; Sigma), and L-NAME (N G -nitro-L-arginine methyl ester; Cayman Chemical, Ann Arbor, MI) were dissolved in killifish Ringer and stored at 4°C; 1-benzylimidazole [1-(phenylmethyl)-1H-imadazole; Cayman] was dissolved in killifish Ringer and stored at Ϫ20°C. Indomethacin [1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid; Sigma] was dissolved in 100 mM NaHCO 3 Ϫ -ethanol (3:1) and stored at 4°C. PGE2, carbaprostacyclin (6,9␣-methylene-11␣,15S-dihydroxy-prosta-5E,13E-dien-1-oic acid), PGD2, PGF2␣, U-46619 (9,11- The research protocols in this study were approved by IACUC committees at the University of Florida and the Mt. Desert Island Biological Laboratory.
All data are expressed as means Ϯ SE. P values for statistical differences were calculated by the appropriate, two-tailed, paired or unpaired Student's t-tests, and concentration-dependence data were analyzed using repeated-measures ANOVA and the appropriate posttests. In the data analysis of all putative inhibitor experiments, each tissue served as its own control when testing the effect of the inhibitor(s), but paired tissues (experimental vs. control) were compared when determining the effect of most of the putative inhibitors on the SRXS6c-mediated inhibition of the I sc. The exception was the COX-1 vs. COX-2 inhibitor study, where SC560 and NS-398 were applied to paired epithelia before SRXS6c was added, and the effect of either on the SRXS6c-mediated inhibition of the I sc was compared with the sum of the control effects of SRXS6c in the previous experiments (L-NAME, indomethacin, etc.). In this case, unpaired statistical analyses were used. In all cases, P Ͻ 0.05 was taken as significant. Specific statistical analyses were performed using Prism (GraphPad Software, San Diego, CA) and are indicated in the text and figure legends.
RESULTS
Preliminary experiments determined that the cumulative addition of ET, sodium nitroprusside (SNP; NO donor), and PGE 2 to both sides of the isolated tissue inhibited the I sc across the operculum, so the ET receptor distribution was examined by comparing the effect of basolateral vs. apical addition of 10 Ϫ7 M ET-1. Addition of ET-1 to the basolateral side of the opercular epithelium inhibited the I sc to the same extent (31.5 Ϯ 3.3%; n ϭ 6) as addition to both sides of the tissue (37.3 Ϯ 8.6%; n ϭ 5; P ϭ 0.52; unpaired t-test, 2 tailed), but addition to the apical side did not produce a significant inhibition of the I sc (8.0 Ϯ 3.9%; n ϭ 7; P ϭ 0.09, t-test vs. zero), suggesting that the endothelin receptors are located on the basolateral surface. Because the effect was maximal after basolateral addition, all subsequent experiments tested the effects of putative agonists or inhibitors after addition to the basolateral solution.
To confirm that the response of the I sc to ET-1 was concentration dependent, and to attempt to delineate the role of ET A vs. ET B receptors, the effects of the cumulative addition of ET-1 (agonist for both ET A and ET B receptors) or SRXS6c (ET B specific) were monitored. Both agonists produced a concentration-dependent inhibition of the I sc , becoming significant at 10 Ϫ8 M and reaching 30-40% at 10 Ϫ7 M in each case (Figs. 1B and 2). ET-1 and SRXS6c were equipotent at all concentrations tested. Because SRXS6c produced significant responses (suggesting the presence of ET B receptors), all subsequent experiments used SRXS6c as an ET agonist, to constrain the study to ET B -mediated effects.
Similar experiments determined the concentration dependence of the response of the I sc to either of two NO donors, SNP (Fig. 1C ) and spermine NONOate (SPNO) or the prostanoids PGE 2 (Fig. 1D ) and carbaprostacyclin (CPR; stable analog of PGI 2 ). Both NO donors (SNP and SPNO) produced a small, concentration-dependent inhibition of the I sc , reaching significance at 10 Ϫ7 and 10 Ϫ6 M, respectively (Fig. 3) . The efficacy of both donors was the same at all concentrations. Both PGE 2 and CPR also produced what appeared to be a concentration-dependent inhibition of the I sc , but only the effect of PGE 2 reached statistical significance (Fig. 4) . PGE 2 was somewhat less effective than either ET or SRXS6c at equivalent concentrations.
Because these experiments determined that ET-1, PGE 2 , and NO donors produced concentration-dependent inhibition of the I sc , interactions between these putative signaling agents were examined by determining the effect of inhibition of either NOS by L-NAME or COX by indomethacin on the baseline (unstimulated) I sc as well as the SRXS6c-mediated inhibition of the I sc . These experiments used paired epithelia from the same animal, and either 10 Ϫ4 M L-NAME or 10 Ϫ5 M indomethacin was added to the experimental tissue, and the same volume of carrier was added to the control tissue. Initial studies determined that any response was relatively rapid, so after 15 min, 10 Ϫ7 M SRXS6c was added to experimental tissue, and an equal volume of the carrier was added to the control tissue, and the I sc was recorded for an additional 30-60 min to equilibrium. Addition of L-NAME to the opercular epithelium stimulated the I sc slightly but significantly (experimental vs. control: 130 Ϯ 10.2 vs. 113 Ϯ 7.99 A/cm 2 ; n ϭ 25; P Ͻ 0.01, paired t-test, 2 tailed). Subsequent addition of SRXS6c inhibited the I sc , but this inhibition was reduced by 17% in those tissues that had been pretreated with the NOS inhibitor ( Table  1 ). Inhibition of COX by indomethacin did not affect the initial I sc (186 Ϯ 37.5 vs. 191 Ϯ 43.6 A/cm 2 ; n ϭ 8; P ϭ 0.79, paired t-test, 2 tailed), but it reduced the SRXS6c-mediated inhibition by nearly 90% (Table 1) .
To determine if the effect of inhibition of NOS and COX (on baseline and SRXS6c inhibition) was additive, in another series of experiments both inhibitors were added to the tissue before the addition of SRXS6c. When L-NAME and indomethacin were added simultaneously, the initial I sc did not change (124 Ϯ 21 vs. 124 Ϯ 26 A/cm 2 ; n ϭ 6; P ϭ 0.99, paired t-test, 2 tailed), demonstrating that the inhibition of COX abolishes the stimulation of the I sc seen when L-NAME is added alone. The presence of both L-NAME and indomethacin inhibited the effect of subsequent addition of SRXS6c by 83% (Table 1) , but the net effect was no greater than the effect of indomethacin alone.
Because NOS-mediated effects may be secondary to chemical interactions of NO with O 2 Ϫ , another series of experiments examined the effects of the spin trap TEMPOL (5 ϫ 10 Ϫ3 M; a superoxide dismutase mimetic) on the baseline and SRXS6c-mediated inhibition of the I sc , as well as the effect of the simultaneous addition of L-NAME, indomethacin, and TEM-POL on these parameters. Addition of TEMPOL had no effect on the initial I sc across the epithelium (256 Ϯ 47.7 vs. 260 Ϯ 47.9 A/cm 2 ; n ϭ 7; P ϭ 0.39, paired t-test, 2 tailed), but it did reduce the SRXS6c-mediated inhibition by 34% (Table 1) , twice the effect of inhibition of NOS by L-NAME (Table 1) . Simultaneous addition of L-NAME, indomethacin, and TEM-POL did not affect the I sc (186 Ϯ 53.4 vs.185 Ϯ 49.2 A/cm 2 ; n ϭ 6; P ϭ 0.90, paired t-test, 2 tailed), but it completely inhibited the effect of subsequent addition of SRXS6c (Table  1 ; percent reduction by SRXS6c not different from zero; P ϭ 0.14).
To attempt to differentiate between COX-1-and COX-2-mediated responses, the effects of SC560 (10 Ϫ6 M; COX-1-specific inhibitor) and NS-398 (10 Ϫ6 M; COX-2-specific inhibitor) on baseline I sc and SRXS6c-mediated inhibition were studied in another series of experiments. Addition of SC560 had no effect on the initial I sc (139 Ϯ 25.5 vs. 138 Ϯ 24.8 A/cm 2 ; n ϭ 5; P ϭ 0.89, paired t-test, 2 tailed), but the addition of NS-398 stimulated the I sc by 16% (150 Ϯ 23.6 vs. 129 Ϯ 20.8 A/cm 2 ; n ϭ 5; P Ͻ 0.01; paired t-test, 2 tailed). Subsequent addition of SRXS6c inhibited the I sc , but previous inhibition of COX-1 reduced this inhibition by 46%, and inhibition of COX-2 reduced the effect by 90% (Table 1) .
Because PGE 2 can bind to any of four receptors (termed EP 1-4 ) , another series of experiments tested the effects of cumulative addition of either butaprost (EP 2 specific) or sul-R562 PARACRINE CONTROL OF FISH GILL TRANSPORT prostone (EP 1/3 specific; e.g., 3) on the I sc across paired opercular epithelia. Butaprost stimulated the I sc across the opercular epithelium in a concentration-dependent manner (reaching significance at 10 Ϫ6 M); sulprostone produced the opposite effect on the I sc , reaching significance at 10 Ϫ7 M (Fig. 5) .
To test the efficacy of other prostanoids, putative agonists (carbaprostacyclin for PGI 2 , U-46619 and I-BOP for thromboxane A 2 , PGF 2␣ , or PGD) were applied to opercular tissues using the same protocol as described for the PGE 2 -mediated concentration-dependence experiments. In addition, the ability of the thromboxane synthase inhibitor 1-benzylimidazole (10 Ϫ5 M) to affect either baseline I sc or SRXS6c-mediated inhibition of the I sc was tested, using the protocol described for L-NAME, indomethacin, and TEMPOL. Neither of the putative TXA 2 agonists (10
Ϫ6 M U-46619 or I-BOP; n ϭ 4) nor PGF 2␣ or PGD 2 (10 Ϫ10 -10 Ϫ6 M; n ϭ 5) produced any change in the I sc across the opercular epithelium (data not shown). Moreover, pretreatment with 1-benzylimidazole had no effect on the unstimulated I sc and did not blunt the SRXS6c-mediated inhibition of the I sc (P ϭ 0.81, paired t-test, 2 tailed; n ϭ 4; data not shown).
DISCUSSION
Our data show that ET-1 and SRXS6c, two NO donors (SNP and SPNO), and PGE 2 each can inhibit the I sc across the opercular epithelium of the killifish Fundulus heteroclitus in a concentration-dependent manner (Figs. 1-4) . This is the first demonstration of a putative role for ET and NO in modulating salt transport across this epithelium, which models the gill epithelium of marine teleost fishes (e.g., 26). Our finding that PGE 2 is inhibitory corroborates earlier studies using the same epithelial preparation (11, 58) . The response to ET is mediated by basolateral receptors, as one might expect; the slight (and statistically insignificant) apical response may be due to leakage of the applied ET from the basolateral to apical surface, or a smaller population of apical receptors may be present, as has been described for other epithelia (e.g., 25). Since the ET Bspecific agonist SRXS6c was as effective as ET-1 in inhibiting the I sc ( Figs. 1 and 2) , we conclude that stimulation of ET B -like receptors mediate this response to ET. Our data do not preclude the presence of ET A receptors in the opercular epithelium, however, but the response of the I sc to ET-1 appears to be wholly via ET B receptors.
The fact that incubation with 10 Ϫ4 M L-NAME produced a small, but significant, stimulation of the I sc suggests that tonic release of NO inhibits the I sc in the unstimulated tissue. However, if COX is also inhibited by the simultaneous addition of 10 Ϫ5 M indomethacin and 10 Ϫ4 M L-NAME, this stimulation is lost (Table 1) . Thus another explanation of the L-NAME-mediated stimulation is that the unstimulated I sc is actually set by the sum of tonic, COX-mediated stimulation and NOS-mediated inhibition. However, inhibition of COX alone by preincubation with 10 Ϫ5 indomethacin did not change the unstimulated I sc , contrary to the inhibition of the I sc one might expect if this model were correct. Moreover, inhibition of COX-2 alone, using the specific inhibitor NS-398, actually stimulated the I sc across the unstimulated tissue, suggesting the presence of a tonic, COX-mediated inhibition of the unstimulated I sc . Thus the current data suggest that both NO and a prostanoid may be tonically controlling the I sc across the unstimulated opercular epithelium, but the net roles of either signaling system cannot be determined from our data.
Despite our uncertainty about the relative roles of NO and prostanoids in tonic control, it is clear that both NO and prostanoids play a role in the response to stimulation of ET B receptors by SRXS6c, but prostanoids are obviously of greater importance (Table 1) . Interestingly, published data suggest that prostanoids, not NO, are also the dominant endothelium-derived relaxing factor in the few fish species that have been studied (e.g., 17, 19, 41) . Inhibition of either NOS or COX did not blunt the SRXS6c effect completely, and addition of both inhibitors simultaneously did not produce an additive response (Table 1) , suggesting some interaction between the putative ET-NO and ET-PG axes and/or the presence of other components in the inhibition produced by activation of the ET B receptor by SRXS6c.
It has become clear that the role of NO in a variety of signaling pathways is at least partially controlled by its effectively instantaneous reaction (K Ϸ 7 ϫ 10 9 mol⅐l Ϫ1 ⅐s Ϫ1 ) with superoxide ions (O 2 Ϫ ) to form peroxynitrite (OONO Ϫ ), an especially toxic molecule (e.g., 30). These three molecules have been termed "the good, the bad, and the ugly" (e.g., 2) because the highly oxidative O 2 Ϫ and OONO Ϫ could produce physiological or pathophysiological responses directly, or merely because O 2 Ϫ removes NO from the system. The fact that the addition of the NO scavenger TEMPOL (5 ϫ 10 Ϫ3 M) blunted the effect of subsequent addition of SRXS6c by 34%, twice the effect of the addition of L-NAME, suggests that O 2 Ϫ itself plays a role in this signaling axis in the opercular epithelium (Table 1) . Indeed, if TEMPOL, L-NAME, and indomethacin were added simultaneously to unstimulated tissue, the effect of subsequent addition of SRXS6c was completely inhibited (Table 1) . Because TEMPOL reduced the effect of SRXS6c significantly more than L-NAME (the NOdependent component), we hypothesize that O 2 Ϫ itself is inhibitory and can be produced by a pathway that is stimulated by ET/SRXS6c. In fact, a recent study demonstrated that ET generated O 2 Ϫ in a COX-dependent pathway after brain injury in newborn pigs (1), so it could be that the TEMPOL-dependent effect on the opercular epithelium is actually the sum of reduction of NO-O 2 Ϫ interactions and reduction of COXgenerated O 2 Ϫ . It is notable that indomethacin alone reduced the SRXS6c effect to the same degree as indomethacin plus L-NAME or indomethacin plus L-NAME and TEMPOL, despite the fact that only the three inhibitors together produce inhibition that is statistically 100% (Table 1 ). This suggests that the COX-mediated prostanoid and O 2 Ϫ production is by far the dominant pathway in the operculum. It is clear that O 2 Ϫ production is not tonic, because TEMPOL did not affect the unstimulated I sc . Garvin's group (42) recently showed that addition of TEMPOL increases the inhibition of Cl Ϫ transport across the THAL of the rat loop of Henle produced by NO. The effect, however, appears to be via inhibition of a stimulatory response to O 2 Ϫ (rather than by removal of O 2 Ϫ and the subsequent stimulation of an NO-mediated inhibition), because exogenous production of O 2
Ϫ by the addition of xanthine oxidase/hypoxanthine stimulated Cl Ϫ transport across the THAL. They concluded, therefore, that O 2 Ϫ itself is stimulatory and not just a modulator of NO concentration (44). Values are means Ϯ SE. n values in parentheses. Isc, short-circuit current; TEMPOL, 4-hydroxy-2,2,6,6-tetramethylpiperidine 1-oxyl; L-NAME, N G -nitro-L-arginine methyl ester.
The fact that pretreatment with NS-398, but not SC560, inhibited the I sc suggests that there may be a COX-2-mediated, tonic inhibition of the I sc , as is the case with NO (see above), in contrast to the indomethacin experiments that suggested that there is COX-mediated, tonic stimulation of the I sc . At this point, we cannot differentiate between these two alternatives, but these experiments do demonstrate that COX-mediated, tonic production of prostanoids may have effects on salt transport across the epithelium, and they also suggest that there may be different roles played by COX-1 vs. COX-2. Because inhibition of COX-2 was twice as effective in attenuating the SRXS6c-mediated inhibition of the I sc as inhibition of COX-1 ( Table 1 ), it appears that both COX-1 and -2 are involved in the production of prostanoids after ET B stimulation in this tissue but that COX-2 is the major effector. The physiological importance of COX-1 and COX-2 has become appreciated in the past few years, and both are expressed in the rat nephron. For instance, a recent study has shown that COX-1 mRNA predominates in the glomerulus, distal tubule, and collecting duct, whereas COX-2 message is localized in the glomerulus and medullary THAL (59) . The genes for the homologues of COX-1 and/or COX-2 have been cloned for the zebrafish (21), two trout species (46, 51) , and dogfish shark (62) , where the clone was amplified from the rectal gland, a functional analog of both the marine teleost gill and THAL of the mammalian nephron (e.g., 40, 52) . The latter study found that the specific COX-2 inhibitor, NS-398, reduced the Cl Ϫ secretion rate of the shark rectal gland. This study suggests that prostanoids are stimulatory, rather than inhibitory, contrary to the present findings and what has been published in the renal literature (e.g., 3). On the other hand, stimulation of salt secretion by the shark rectal gland has the same effect as inhibition of salt uptake by the mammalian nephron: increased salt excretion.
Because the PGE 2 receptors EP 1 and EP 3 predominate in mammalian renal tubules (e.g., 3), we attempted to differentiate between putative receptors in the killifish operculum by comparing the efficacy of the relatively specific agonists, butaprost (EP 2 ), and sulprostone (EP 1/3 ) in this system. The fact that butaprost produced a concentration-dependent stimulation and sulprostone produced a concentration-dependent inhibition (Fig. 5) suggests that EP 2 and EP 1 (and/or EP 3 ) receptors are present and that release of PGE 2 in the opercular epithelium can produce stimulation or inhibition, depending on the distribution of the respective receptors. Our data suggest that inhibitory receptors (EP 1 and/or EP 3 ) predominate, but the finding that the L-NAME-induced stimulation of the I sc is inhibited by the simultaneous addition of indomethacin suggests the presence of at least some stimulatory receptors. The actual receptors present could be identified by immunological or molecular techniques, as well as measurement of intracellular second messengers in the future. It is important to note, however, that early work on the killifish operculum demonstrated that the I sc could be stimulated by isoproterenol and inhibited by epinephrine and arterenol (10) and subsequent studies showed that the stimulation vs. inhibition is mediated by ␤-adrenergic and ␣-adrenergic receptors, respectively (37) . In the killifish operculum, ␤-adrenergic receptors stimulate intracellular cAMP (38) and ␣-adrenergic receptors stimulate intracellular inositol triphosphate (34) , parallel to at least EP 2 and EP 1 , respectively. Thus the intracellular second messengers for the putative EP receptors that our data suggest appear to be present in the opercular epithelium.
The inability of thromboxane A 2 agonists or PGF 2␣ and PGD 2 to elicit a change in the I sc across opercular skin suggests that, if receptors for these other prostanoids are present in this tissue, they play a minor role in modulating the transport of NaCl across this tissue. The inability of a TXA 2 synthase inhibitor to reduce the SRXS6c-mediated reduction in the I sc supports this conclusion. The putative PGI 2 agonist CPR was not as effective as PGE 2 in inhibiting the I sc and the effect was not statistically significant (Fig. 4) , which suggests that IP receptors are not important in this system. CPR, on the other hand, can also bind to the EP 1 receptor (e.g., 3), and the PGE 2 and the sulprostone data suggest that the EP 1 or EP 3 receptor mediates the majority of the inhibition seen after SRXS6c addition.
Our data are the first to suggest that ET can modulate salt transport across the killifish opercular epithelium. It is unclear what stimulus activates the ET receptor (presumably ET B ); changes in plasma osmolarity or cardiovascular parameters, or other signaling agents, might be suggested to be the putative stimuli. Nevertheless, our data suggest that activation of the ET B receptor stimulates the production of NO, O 2 Ϫ , and prostanoids (probably PGE 2 ), each of which inhibit the transport of NaCl. Prostanoids probably account for 70-90% of the inhibition, even when accounting for what appears to be a significant role for O 2 Ϫ in this system. It is not clear if NO plays a direct role or merely modifies O 2 Ϫ concentrations. COX-2 and COX-1 are both involved in the synthesis of the active prostanoid (as well as O 2 Ϫ ), although COX-2 appears to play a much bigger role. Both stimulatory (EP 2 ) and inhibitory Fig. 6 . Working hypothesis for the putative pathways of ET-inhibited NaCl transport across the fish gill. Two cells are diagramed, but the system may be expressed within a single cell. Width of the arrows is proportional to the presumed importance of the specific pathway in the axis. See text for details. ET-1, endothelin; ETB, endothelin B receptor; NOS, nitric oxide synthase; COX-2, cyclooxygenase-2; NO, nitric oxide; EP1, PGE2 receptor; O2
Ϫ , superoxide ion; ONOO Ϫ , peroxynitrite ion.
(EP 1/3 ) PGE receptors appear to be involved, although inhibition appears to be the most significant response. Our data do not allow a definitive model for the roles of NO and prostanoids in maintaining the unstimulated salt transport across this epithelium, but some aspects of this work provide evidence for some role for both effectors without any stimulation of the ET receptor. Figure 6 summarizes our current working hypothesis for the interactions between ET, NO, O 2 Ϫ , and PGE 2 in inhibiting salt extrusion by the marine teleost gill epithelium, as modeled by the killifish opercular epithelium.
Perspectives
Because the opercular epithelium is the generally accepted model for the marine teleost fish branchial epithelium (see introduction), our data provide the first evidence that salt extrusion by the gill can be modulated by release of paracrine agents, in this case: ET, NO, O 2 Ϫ , and PGE 2 . Although we provide some evidence for a stimulatory prostanoid pathway, the bulk of the data suggest ET-stimulated and NO-O 2 Ϫ -PGE 2 -mediated inhibition of salt transport. The result would be salt retention, because the gill is the dominant site of salt secretion in marine teleosts (e.g., 24 ). This signaling pathway, therefore, has the opposite final result from that found in the mammalian kidney, where ET, NO, and prostanoids are predominantly natriuretic because of inhibition of uptake in the renal tubules (see introduction). Because salt retention is important in fish in hypoosmotic environments (e.g., 13), we hypothesize that this paracrine modulating system is most important in freshwater species or euryhaline species as they enter freshwater. Indeed, gill tissue from the eel produces significantly more prostanoids (actually, PGD 2 and 6-keto-F 1␣ ) after acclimation to freshwater (5). Interestingly, PGE 2 concentrations were very low in this tissue, as well as trout gill, in this study, and no significant changes in PGE 2 concentrations were seen in either species after acclimation to freshwater vs. seawater (5) .
The cellular site of ET, NO, and prostanoid production (as well as cellular receptors) in the teleost gill is currently under investigation. Zaccone's group (64) demonstrated immunoreactivity for big-ET (ET prohormone) and NOS in what they term "neuroendocrine" cells in the branchial epithelium from a variety of teleosts and elasmobranchs. Our preliminary studies (12; and K. A. Hyndman, P. M. Piermarini, and D. H. Evans, unpublished observations) have localized immunoreactive NOS in cells distinct from the mitochondrion-rich cells (MRC; Cl Ϫ transporting) in both the killifish opercular epithelium and gill epithelium, but it is not clear if these are "neuroendocrine," mucous, or pavement cells. In the stingray gill, we find immunoreactive big-ET is in the MRC and COX is expressed in the filamental central venous sinus, but in the killifish gill big-ET can be localized to epithelial cells distinct from the MRC, and COX is seen in the MRC. Thus it is clear that species differences may exist; nevertheless, localization of the effectors and receptors for this new signaling axis is of great interest for comparative vertebrate physiology and may provide new insights into paracrine control axes in the mammalian kidney. 
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